| |
| Issue |
Title |
| |
| Vol 23, No 9 (2024) |
Reverse myocardial remodeling according to cardiac magnetic resonance imaging in patients with heart failure and atrial fibrillation receiving dapagliflozin |
Abstract
PDF (Rus)
|
|
K. M. Saipudinova, T. M. Uskach, M. A. Sharia, D. V. Ustyuzhanin, S. N. Tereshchenko |
| |
| Vol 23, No 7 (2024) |
Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fraction and abdominal obesity |
Abstract
PDF (Rus)
|
|
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, Ya. V. Polonskaya, E. V. Kashtanova |
| |
| Vol 23, No 5 (2024) |
Frequency of dyspnea related to intake of ticagrelor or clopidogrel in patients with chronic coronary syndrome undergoing coronary intervention |
Abstract
PDF (Eng)
|
|
Dunya Habeeb Shnain, Ghassan Mohammed Mahmood, Sara Omar Ahmed |
| |
| Vol 23, No 5 (2024) |
Long-term anticoagulant therapy in the aspect of secondary prevention of recurrent pulmonary embolism |
Abstract
PDF (Rus)
|
|
E. A. Shmidt, T. Yu. Penskaya, O. V. Gruzdeva, S. A. Berns, V. N. Karetnikova, O. L. Barbarash |
| |
| Vol 22, No 10 (2023) |
Practical use of idarucizumab |
Abstract
PDF (Rus)
|
|
G. R. Ramazanov, E. A. Kovaleva, E. V. Klychnikova, S. S. Petrikov, N. A. Shamalov, I. S. Aliev, E. V. Shevchenko |
| |
| Vol 22, No 7 (2023) |
Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor in acute coronary syndrome |
Abstract
PDF (Rus)
|
|
S. V. Lukyanov, Yu. F. Glukhov, E. V. T., B. M. Tankhilevich, D. A. Zateyshchikov, T. V. Khlevchuk, I. B. Bondareva |
| |
| Vol 22, No 8 (2023) |
Endothelial protective effect of pitavastatin |
Abstract
PDF (Rus)
|
|
A. S. Berns, V. V. Kashtalap |
| |
| Vol 22, No 8 (2023) |
Lipid metabolism disorders in patients with hypertension and diabetes mellitus: development and current treatment options |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, A. I. Tarzimanova, A. A. Abramova, M. V. Vetluzhskaya, I. D. Medvedev, I. Zh. Loria |
| |
| Vol 22, No 1 (2023) |
Novel approaches to the comprehensive assessment of the quality and adherence to pharmacotherapy and its use in cardiovascular patients |
Abstract
PDF (Rus)
|
|
Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. M. Drapkina |
| |
| Vol 21, No 12 (2022) |
Reactogenicity of various COVID-19 vaccination regimens |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, S. A. Berns, A. Yu. Gorshkov, L. N. Ryzhakova, O. V. Zhdanova, M. G. Chaschin, O. A. Litinskaya |
| |
| Vol 21, No 12 (2022) |
Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 |
Abstract
PDF (Rus)
|
|
N. P. Kutishenko, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, А. А. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina |
| |
| Vol 21, No 9 (2022) |
Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke |
Abstract
PDF (Rus)
|
|
O. A. Osipova, A. N. Ilnitsky, E. V. Gosteva, S. G. Gorelik, L. V. Vasilyeva, N. I. Klyushnikov, N. I. Golovina, Yu. V. Tatarintseva, Yu. A. Lykov |
| |
| Vol 21, No 8 (2022) |
Efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion |
Abstract
PDF (Rus)
|
|
D. V. Pevsner, Yu. K. Rytova, I. Merkulova, E. V. Merkulov |
| |
| Vol 21, No 8 (2022) |
Lipid-lowering therapy: modern possibilities and real clinical practice |
Abstract
PDF (Rus)
|
|
A. V. Blokhina, A. I. Ershova, A. N. Meshkov, N. M. Akhmedzhanov, A. A. Ivanova, K. A. Guseinova, S. A. Smetnev, O. A. Litinskaya, S. A. Boytsov, A. M. Drapkina |
| |
| Vol 21, No 6 (2022) |
Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome |
Abstract
PDF (Rus)
|
|
O. A. Osipova, V. P. Mikhin, A. I. Golovin, O. N. Belousova, D. N. Perutsky, P. K. Alferov, S. L. Konstantinov |
| |
| Vol 21, No 7 (2022) |
Pleiotropic vasoprotective effects of high-dose atorvastatin therapy in the context of achieving the target low-density lipoprotein cholesterol in patients after myocardial infarction |
Abstract
PDF (Rus)
|
|
L. I. Salyamova, A. A. Khromova, O. G. Kvasova, K. N. Korenkova, K. N. Polezhaeva, N. A. Donetskaya, K. I. Pavlenko |
| |
| Vol 21, No 7 (2022) |
Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19 |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, E. S. Ogibenina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov |
| |
| Vol 21, No 3 (2022) |
Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial |
Abstract
PDF (Rus)
|
|
S. B. Fitilev, Yu. F. Glukhov, S. V. Lukyanov, A. V. Vozzhaev, I. I. Shkrebniova, V. I. Kazey, I. B. Bondareva |
| |
| Vol 21, No 3 (2022) |
Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic |
Abstract
PDF (Rus)
|
|
E. V. Sayutina, L. I. Butorova, E. M. Tuaeva, M. A. Osadchuk, M. M. Shamuilova |
| |
| Vol 20, No 8 (2021) |
Effects of Pharmacy Care Program on medication adherence in outpatients with stable coronary artery disease: a randomized controlled study |
Abstract
PDF (Rus)
|
|
S. B. Fitilev, A. V. Vozzhaev, D. A. Klyuev, I. I. Shkrebniova, N. N. Shindryaeva, L. N. Saakova, Yu. V. Shkirando |
| |
| Vol 20, No 8 (2021) |
Dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers |
Abstract
PDF (Rus)
|
|
O. A. Osipova, E. V. Gosteva, O. N. Belousova, S. G. Gorelik, N. I. Klyushnikov, Yu. A. Lykov, A. N. Khachaturov, V. V. Bukatov |
| |
| Vol 20, No 8 (2021) |
Effectiveness of lipid-lowering therapy in outpatients with coronary artery disease living in a large industrial center of Eastern Siberia |
Abstract
PDF (Rus)
|
|
N. G. Gogolashvili, R. A. Yaskevich |
| |
| Vol 20, No 7 (2021) |
Comparative effectiveness of statin therapy in patients with hypertension of high and very high cardiovascular risk in actual clinical practice in Irkutsk |
Abstract
PDF (Rus)
|
|
O. A. Ivanova, S. G. Kuklin, S. S. Sizova, T. A. Novoselova, L. R. Gaifullina |
| |
| Vol 20, No 7 (2021) |
Effect of angiotensin II receptor blocker therapy on markers of fibrosis and immune inflammation in hypertensive patients with chronic kidney disease after ischemic stroke |
Abstract
PDF (Rus)
|
|
O. A. Osipova, E. V. Gosteva, O. N. Belousova, T. P. Golivets, J. Yu. Chefranova, Yu. A. Lykov, A. N. Khachaturov, N. I. Golovina |
| |
| Vol 20, No 7 (2021) |
Natriuretic peptides: new challenges — new solutions |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, R. N. Shepel, O. N. Dzhioeva |
| |
| Vol 20, No 5 (2021) |
Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS) |
Abstract
PDF (Rus)
|
|
A. I. Tarzimanova, V. L. Doshchitsin |
| |
| Vol 20, No 4 (2021) |
Direct oral anticoagulants for electrical cardioversion |
Abstract
PDF (Rus)
|
|
A. N. Volovchenko, D. A. Andreev, D. F. Mesitskaya |
| |
| Vol 20, No 5 (2021) |
Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter |
Abstract
PDF (Rus)
|
|
M. V. Serova, D. A. Andreev, M. I. Chashkina, Z. K. Salpagarova |
| |
| Vol 19, No 5 (2020) |
Lipid-lowering therapy in outpatients of different ages with coronary artery disease |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, N. N. Landyshev, Ya. G. Voronko, A. M. Lutsenko |
| |
| Vol 19, No 5 (2020) |
Modern treatment of supraventricular tachycardia |
Abstract
PDF (Rus)
|
|
A. I. Tarzimanova, V. I. Podzolkov |
| |
| Vol 19, No 5 (2020) |
Statin therapy in patients with high and very high cardiovascular risk: an optimal approach |
Abstract
PDF (Rus)
|
|
E. V. Sayutina, M. M. Shamuilova, L. I. Butorova, E. M. Tuayeva, A. L. Vertkin |
| |
| Vol 19, No 4 (2020) |
Modern view on the therapy of chronic venous insufficiency with micronized purified flavonoid fraction |
Abstract
PDF (Rus)
|
|
H. M. Kurginyan, V. V. Raskin |
| |
| Vol 19, No 4 (2020) |
Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years? |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Klyuev, L. N. Stepanyan, A. A. Danilova, A. T. Tsai, N. N. Landyshev, Ya. G. Voronko |
| |
| Vol 19, No 2 (2020) |
The effect of single and dual antiplatelet therapy on the activity of pro-inflammatory cytokines in patients with coronary artery disease and obstructive sleep apnea |
Abstract
PDF (Rus)
|
|
V. I. Ruzov, L. G. Komarova, A. S. Komarov, A. M. Vorobev, L. N. Savonenkova, O. V. Midlenko |
| |
| Vol 19, No 2 (2020) |
Acquisition of renin-angiotensin-aldosterone system inhibitors for the treatment of cardiovascular diseases in regions of the Far Eastern Federal District |
Abstract
PDF (Rus)
|
|
M. S. Soboleva, E. E. Loskutova |
| |
| Vol 19, No 2 (2020) |
Aspirin-induced gastrointestinal lesions in patients with chronic coronary artery disease: special aspects and therapeutic options |
Abstract
PDF (Rus)
|
|
N. Yu. Borovkova, M. V. Buyanova, V. V. Terekhova, T. E. Bakka, M. P. Nistratova, T. V. Vlasova |
| |
| Vol 18, No 6 (2019) |
Evolution of dyslipidemia: from etiological mechanisms to new targets of personalized preventive nutraceutical therapy with red yeast rice |
Abstract
PDF (Rus)
|
|
O. Sh. Oinotkinova, E. L. Nikonov, E. V. Kryukov, A. P. Baranov, M. I. Voevoda |
| |
| 1 - 37 of 37 Items |
|
